Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Gidazepam
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Trade names | Gidazepam IC |
Routes of administration |
Oral |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Elimination half-life | 86,7 hours(for active metabolite) |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C17H15BrN4O2 |
Molar mass | 387.2 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Gidazepam, also known as hydazepam or hidazepam, is a drug which is an atypical benzodiazepine derivative, developed in the Soviet Union. It is a selectively anxiolytic benzodiazepine. It also has therapeutic value in the management of certain cardiovascular disorders.
Gidazepam is a prodrug for its active metabolite 7-bromo-2,3-dihydro-5-phenyl-1H-1,4-benzodiazepin-2-one (desalkylgidazepam or bromo-nordazepam). It is used as an antianxiety drug. Its anxiolytic effects can take several hours to manifest after dosing however, as it is the active metabolite which primarily gives the anxiolytic effects, and Gidazepam's half-life is among the longest of all GABA-ergic agonists.
See also
- Phenazepam—another benzodiazepine widely used in Russia and other CIS countries
- Cinazepam
- Cloxazolam
5-HT1AR agonists | |
---|---|
GABAAR PAMs |
|
Gabapentinoids |
|
Antidepressants |
|
Sympatholytics |
|
Others | |
|